Immunological memory to SARS-CoV-2 assessed for up to 8 months after infection.

Dan, Jennifer M., Mateus, Jose, Kato, Yu, Hastie, Kathryn M., Yu, Esther Dawen, Faliti, Caterina E., Grifoni, Alba, Ramirez, Sydney I. +13 more·2021·Science

DOI 10.1126/science.abf4063

Cited by (1,011)

Items 501–600 of 1,011

Immune memory in convalescent patients with asymptomatic or mild COVID-19
Quanxin Long, Yanjun Jia, Xin Wang, Haijun Deng, Xiaoxia Cao, Jun Yuan, Liang Fang, Xu-Rong Cheng, Chao Luo, An-Ran He et al. · 2021 · Cell Discovery
Seropositivity in blood donors and pregnant women during the first year of SARS‐CoV‐2 transmission in Stockholm, Sweden
Xaquín Castro Dopico, Sandra Muschiol, Murray Christian, Leo Hanke, Daniel J. Sheward, Nastasiya F. Grinberg, Joanna Rorbach, Gordana Bogdanović, Gerald M. McInerney, Tobias Allander et al. · 2021 · Journal of Internal Medicine
The plasmablast response to SARS-CoV-2 mRNA vaccination is dominated by non-neutralizing antibodies and targets both the NTD and the RBD
Fatima Amanat, Mahima Thapa, Tinting Lei, Shaza M. Sayed Ahmed, Daniel C. Adelsberg, Juan Manuel Carreño, Shirin Strohmeier, Aaron J. Schmitz, Sarah Zafar, Julian Q. Zhou et al. · 2021 · medRxiv
Insights into neutralizing antibody responses in individuals exposed to SARS-CoV-2 in Chile
Carolina Beltrán-Pavez, Sebastián Riquelme-Barrios, Aarón Oyarzún-Arrau, Aracelly Gaete-Argel, Roxana González‐Stegmaier, Karina Cereceda, Adam Aguirre, Dante Travisany, Ricardo Palma-Véjares, Gonzalo P. Barriga et al. · 2021 · Science Advances
Production and persistence of specific antibodies in COVID-19 patients with hematologic malignancies: role of rituximab
Chiara M. Cattaneo, Valeria Cancelli, Luisa Imberti, Kerry Dobbs, Alessandra Sottini, Chiara Pagani, Angelo Belotti, Alessandro Re, A. Anastasia, Virginia Quaresima et al. · 2021 · Blood Cancer Journal
Insights into COVID-19 Vaccine Development Based on Immunogenic Structural Proteins of SARS-CoV-2, Host Immune Responses, and Herd Immunity
J. Chaudhary, R. Yadav, P. Chaudhary, Anurag Maurya, Nimita Kant, O. Al Rugaie, H. Haokip, Deepika Yadav, Rakesh P. N. Roshan, R. Prasad et al. · 2021 · Cells
mRNA vaccine-induced antibodies more effective than natural immunity in neutralizing SARS-CoV-2 and its high affinity variants
Yunkai Yu, Dominic Esposito, Zhigang Kang, Jianming Lü, Alan Thomas Remaley, Valeria De Giorgi, Leonard N. Chen, Kamille A. West, Liang Cao · 2022 · Scientific Reports
Modeling waning and boosting of COVID-19 in Canada with vaccination
Lauren M. Childs, David W. Dick, Zhilan Feng, Jane Marie Heffernan, Jing Li, Gergely Röst · 2022 · Epidemics
Impact of SARS-CoV-2 exposure history on the T cell and IgG response
Roanne S. Keeton, Marius Belmondo Tincho, Akiko Suzuki, Ntombi Benede, Amkele Ngomti, Richard Baguma, Masego V. Chauke, Mathilda Mennen, Sango Skelem, Marguerite Adriaanse et al. · 2022 · Cell Reports Medicine
COVID-19 vaccines: Immune correlates and clinical outcomes
Shant H. Mahrokhian, Lisa H. Tostanoski, Samuel J. Vidal, Dan H. Barouch · 2024 · Human Vaccines & Immunotherapeutics
Antigen‐dependent multistep differentiation of T follicular helper cells and its role in SARS‐CoV‐2 infection and vaccination
Dirk Baumjohann, Nicolas Fazilleau · 2021 · European Journal of Immunology
SARS‐CoV‐2‐specific CD8+ T‐cell responses and TCR signatures in the context of a prominent HLA‐A*24:02 allomorph
Louise C. Rowntree, Jan Petersen, Jennifer A. Juno, Priyanka Chaurasia, Kathleen M. Wragg, Marios Koutsakos, Luca Hensen, Adam K. Wheatley, Stephen John Kent, Jamie Rossjohn et al. · 2021 · Immunology and Cell Biology
Duration of SARS-CoV-2 sero-positivity in a large longitudinal sero-surveillance cohort: the COVID-19 Community Research Partnership
David M. Herrington, John W. Sanders, Thomas F. Wierzba, Martha A. Alexander‐Miller, Mark Andrew Espeland, Alain Gerald Bertoni, Allison Mathews, Austin Lyles Seals, Iqra Munawar, Michael S. Runyon et al. · 2021 · BMC Infectious Diseases
From first to second wave: follow-up of the prospective COVID-19 cohort (KoCo19) in Munich (Germany)
Katja Radon, Abhishek Bakuli, Peter Pütz, Ronan Le Gleut, Jessica Michelle Guggenbuehl Noller, Laura Olbrich, Elmar Saathoff, Mercè Garí, Yannik Schälte, Turid Frahnow et al. · 2021 · BMC Infectious Diseases
Of bats and men: Immunomodulatory treatment options for COVID-19 guided by the immunopathology of SARS-CoV-2 infection
Michael J. Christie, Aaron Trent Irving, Samuel C. Forster, Benjamin J. Marsland, Philip M. Hansbro, Paul J. Hertzog, Claudia A. Nold‐Petry, Marcel F. Nold · 2021 · Science Immunology
Older Adults Mount Less Durable Humoral Responses to Two Doses of COVID-19 mRNA Vaccine but Strong Initial Responses to a Third Dose
Francis M. Mwimanzi, Hope R. Lapointe, Peter K. Cheung, Yurou Sang, Fatima Yaseen, Gisele Umviligihozo, Rebecca Kalikawe, Sneha Datwani, F. Harrison Omondi, Laura Burns et al. · 2022 · The Journal of Infectious Diseases
Safety and immunogenicity of an AS03-adjuvanted plant-based SARS-CoV-2 vaccine in Adults with and without Comorbidities
Nathalie Charland, Philipe Gobeil, Stéphane Pillet, Iohann Boulay, Annie Séguin, Alexander I. Makarkov, Gretchen Heizer, Kapil Bhutada, Asif Mahmood, Sonia Trépanier et al. · 2022 · npj Vaccines
Impact of SARS-CoV-2 infection and COVID-19 on patients with inborn errors of immunity
Stuart G. Tangye, Laurent Abel, Salah Al-Muhsen, Alessandro Aiuti, Saleh Al‐Muhsen, Fahd Al‐Mulla, Mark Stuart Anderson, Evangelos Andreakos, Antonio Novelli, Andrés Augusto Arias et al. · 2022 · Journal of Allergy and Clinical Immunology
What level of neutralising antibody protects from COVID-19?
Khoury, David S, Cromer, Deborah, Reynaldi, Arnold, Schlub, Timothy E, Wheatley, Adam K, Juno, Jennifer A, Subbarao, Kanta, Kent, Stephen J, Triccas, James A, Davenport, Miles P · 2021
Anti- SARS-CoV-2 Receptor Binding Domain Antibody Evolution after mRNA Vaccination
Cho, Alice, Muecksch, Frauke, Schaefer-Babajew, Dennis, Wang, Zijun, Finkin, Shlomo, Gaebler, Christian, Ramos, Victor, Cipolla, Melissa, Mendoza, Pilar, Agudelo, Marianna et al. · 2021
Serological response to COVID-19 vaccination in patients with cancer older than 80 years
Daniela Iacono, Linda Cerbone, Lucia Palombi, Elena Cavalieri, Isabella Sperduti, Rosario Andrea Cocchiara, Bruno Mariani, Gabriella Parisi, Carlo Garufi · 2021 · Journal of Geriatric Oncology
Decline of antibody titres 3 months after two doses of BNT162b2 in non-immunocompromised adults
Alejo Erice, David Varillas‐Delgado, Cristina Caballero · 2021 · Clinical Microbiology and Infection
Differences in IgG Antibody Responses following BNT162b2 and mRNA-1273 SARS-CoV-2 Vaccines
José Gilberto Montoya, Amy E. Adams, Valérie Bonetti, Sien Deng, Nan A. Link, Suzanne Pertsch, Kjerstie Olson, Martina Li, Ellis C. Dillon, Dominick L. Frosch · 2021 · Microbiology Spectrum
Humoral antibody kinetics with ChAdOx1-nCOV (Covishield™) and BBV-152 (Covaxin™) vaccine among Indian Healthcare workers: A 6-month longitudinal cross-sectional Coronavirus Vaccine-induced antibody titre (COVAT) study
Awadhesh Kumar Singh, Sanjeev Phatak, Ritu Singh, Kingshuk Bhattacharjee, Nagendra Kumar Singh, Arvind Gupta, Arvind Sharma · 2022 · Diabetes & Metabolic Syndrome Clinical Research & Reviews
SARS-CoV-2 infection and vaccination trigger long-lived B and CD4+ T lymphocytes with implications for booster strategies
Alessio Mazzoni, Anna Vanni, Michele Spinicci, Giulia Lamacchia, Seble Tekle Kiros, Arianna Rocca, Manuela Capone, Nicoletta Di Lauria, Lorenzo Salvati, Alberto Carnasciali et al. · 2022 · Journal of Clinical Investigation
Enhanced SARS-CoV-2 humoral immunity following breakthrough infection builds upon the preexisting memory B cell pool
Timm Weber, Sabrina Dähling, Svea Rose, Patrick Affeldt, Kanika Vanshylla, Leon Ullrich, Lutz Gieselmann, Finn Teipel, Henning Gruell, Veronica Di Cristanziano et al. · 2023 · Science Immunology
SARS-CoV-2 breakthrough infections enhance T cell response magnitude, breadth, and epitope repertoire
Alison Tarke, Parham Ramezani-Rad, Tertuliano Alves Pereira Neto, Yeji Lee, Vanessa Silva‐Moraes, Benjamin Goodwin, Nathaniel I. Bloom, Leila Siddiqui, Liliana Avalos, April Frazier et al. · 2024 · Cell Reports Medicine
Changes in humoral immune response after SARS-CoV-2 infection in liver transplant recipients compared to immunocompetent patients
A. Marcos, Magdalena Salcedo, Roberto Alonso, Manuel Rodríguez‐Perálvarez, María Olmedo, Javier Graus Morales, Valentín Cuervas‐Mons, Alba Cachero, Carmelo Loinaz, Mercedes Iñarrairaegui et al. · 2021 · American Journal of Transplantation
Severe Acute Respiratory Syndrome Coronavirus 2 Cumulative Incidence, United States, August 2020–December 2020
Patrick Sean Sullivan, Aaron Julius Siegler, Kayoko Shioda, Eric W Hall, Heather M. Bradley, Travis Sanchez, Nicole Luisi, Mariah Valentine-Graves, Kristin Nelson, Mansour Fahimi et al. · 2021 · Clinical Infectious Diseases
T cell response against SARS-CoV-2 persists after one year in patients surviving severe COVID-19
Fabienne Venet, Morgane Gossez, Frank Bidar, Maxime Bodinier, Rémy Coudereau, Anne‐Claire Lukaszewicz, Claire Tardiveau, Karen Brengel‐Pesce, Valérie Cheynet, Marie-Angélique Cazalis et al. · 2022 · EBioMedicine
Safety and immunogenicity of an inactivated SARS-CoV-2 vaccine in healthy adults aged 18 years or older: A randomized, double-blind, placebo-controlled, phase 1/2 trial
Wanshen Guo, Kai Duan, Yuntao Zhang, Zhiming Yuan, Yanbo Zhang, Zejun Wang, Dongyang Zhao, Huajun Zhang, Zhiqiang Xie, Xinguo Li et al. · 2021 · EClinicalMedicine
Immune Response to SARS-CoV-2 Vaccines
Navya Bellamkonda, Upendra Pradeep Lambe, Sonali Ankush Sawant, Shyam Sundar Nandi, Chiranjib Chakraborty, Deepak Shukla · 2022 · Biomedicines
New insights into the pathogenesis of SARS-CoV-2 during and after the COVID-19 pandemic
Jonatan J. Carvajal, Valeria García-Castillo, Shelsy V. Cuellar, Claudia P. Campillay-Véliz, Camila Salazar‐Ardiles, Andrea M. Avellaneda, Christian A. Muñoz, Angello R Retamal-Díaz, Susan M. Bueno, Pablo A. González et al. · 2024 · Frontiers in Immunology
Immune Responses to SARS-CoV-2 in Solid Organ Transplant Recipients
Varun K. Phadke, Nicholas Scanlon, Stanley C. Jordan, Nadine Rouphael · 2021 · Current Transplantation Reports
Characterization of an attenuated SARS-CoV-2 variant with a deletion at the S1/S2 junction of the spike protein
Pui Wang, Siu-Ying Lau, Shaofeng Deng, Pin Chen, Bobo Wing-Yee Mok, Jinxia Zhang, Andrew Chak-Yiu Lee, Kwok‐Hung Chan, Rachel Chun-Yee Tam, Haoran Xu et al. · 2021 · Nature Communications
Exploring the therapeutic potential of forkhead box O for outfoxing COVID-19
Pradeep Singh Cheema, Deeptashree Nandi, Alo Nag · 2021 · Open Biology
Different Neutralization Sensitivity of SARS-CoV-2 Cell-to-Cell and Cell-Free Modes of Infection to Convalescent Sera
Kruglova, Natalia, Siniavin, Andrei, Gushchin, Vladimir, Mazurov, Dmitriy · 2021 · Viruses
T follicular helper cells in the humoral immune response to SARS-CoV-2 infection and vaccination
Marios Koutsakos, Wen Shi Lee, Adam K Wheatley, Stephen J Kent, Jennifer A. Juno · 2021 · Journal of Leukocyte Biology
SARS-CoV-2–specific memory B cells can persist in the elderly who have lost detectable neutralizing antibodies
Anna Jeffery-Smith, Alice R. Burton, Sabela Lens, Chloe Rees-Spear, Jessica E. Davies, Monika Patel, Robin Gopal, Luke Muir, Felicity Aiano, Katie J. Doores et al. · 2021 · Journal of Clinical Investigation
Divergent trajectories of antiviral memory after SARS-CoV-2 infection
Adriana Tomić, Donal Skelly, Ane Ogbe, Daniel O’Connor, Matthew J. Pace, Emily Adland, Frances Alexander, Mohammad Ali, Kirk Allott, M. Azim Ansari et al. · 2022 · Nature Communications
Heterologous ChAdOx1/BNT162b2 vaccination induces stronger immune response than homologous ChAdOx1 vaccination: The pragmatic, multi-center, three-arm, partially randomized HEVACC trial
Zoltán Bánki, José Mateus, Annika Rössler, Helena Schäfer, David Bante, Lydia Riepler, Alba Grifoni, Alessandro Sette, Viviana R. Simon, Barbara Falkensammer et al. · 2022 · EBioMedicine
Longitudinal Assessment of SARS-CoV-2-Specific T Cell Cytokine-Producing Responses for 1 Year Reveals Persistence of Multicytokine Proliferative Responses, with Greater Immunity Associated with Disease Severity
Jonah Lin, Ryan Law, Chapin S. Korosec, Christine Yang Zhou, Wan Hon Koh, Mohammad Sajjad Ghaemi, Philip Samaan, Hsu Kiang Ooi, Vitaliy A. Matveev, FengYun Yue et al. · 2022 · Journal of Virology
Reduced binding and neutralization of infection- and vaccine-induced antibodies to the B.1.351 (South African) SARS-CoV-2 variant
Venkata Viswanadh Edara, Carson Norwood, Katharine A. Floyd, Lilin Lai, Meredith E. Davis-Gardner, William H. Hudson, Grace E. Mantus, Lindsay E. Nyhoff, Max W. Adelman, Rebecca Fineman et al. · 2021 · bioRxiv (Cold Spring Harbor Laboratory)
Decline and loss of anti–SARS-CoV-2 antibodies in kidney transplant recipients in the 6 months following SARS-CoV-2 infection
Nathalie Chavarot, Marianne Leruez‐Ville, Anne Scemla, Carole Burger, Lucile Amrouche, Claire Rouzaud, Xavier Lebreton, Frank Martinez, Rébecca Sberro‐Soussan, Christophe M. Legendre et al. · 2021 · Kidney International
Immunogenicity after two doses of inactivated virus vaccine in healthcare workers with and without previous COVID‐19 infection: Prospective observational study
Tuğba Yanık Yalçın, Deniz İlhan Topçu, Özlem Doğan, Saliha Aydın, Nuran Sarı, Çiğdem Erol, Zeynep Ece Kuloğlu, Özlem Kurt Azap, Füsun Can, Hande Arslan · 2021 · Journal of Medical Virology
Protective Immunity after Natural Infection with Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2) – Kentucky, USA, 2020
Kevin B. Spicer, Connor Glick, Alyson M. Cavanaugh, Douglas A. Thoroughman · 2021 · International Journal of Infectious Diseases
SARS-CoV-2 mRNA vaccine BNT162b2 triggers a consistent cross-variant humoral and cellular response
Davide Mileto, Claudio Fenizia, Miriam Cutrera, G. Gagliardi, Anna Gigantiello, Annalisa De Silvestri, Alberto Rizzo, Alessandro Mancon, Martina Bianchi, Fernando Poli et al. · 2021 · Emerging Microbes & Infections
A Single Vaccine Protects against SARS-CoV-2 and Influenza Virus in Mice
Kangli Cao, Xiang Wang, Haoran Peng, Longfei Ding, Xiangwei Wang, Yangyang Hu, Lanlan Dong, Tianhan Yang, Xiujing Hong, Man Xing et al. · 2021 · Journal of Virology
Initial immune response after exposure to Mycobacterium tuberculosis or to SARS-COV-2: similarities and differences
A. Aiello, Saeid Najafi-Fard, D. Goletti · 2023 · Frontiers in Immunology
Prevalence and incidence of anti-SARS-CoV-2 antibodies among healthcare workers in Belgian hospitals before vaccination: a prospective cohort study
Laure Mortgat, Kristien Verdonck, Veronik Hutse, Isabelle Thomas, Cyril Barbezange, Leo Heyndríckx, Natalie Fischer, Béa Vuylsteke, Ines Kabouche, Kevin K. Ariën et al. · 2021 · BMJ Open
Evaluation of a surrogate virus neutralization test for high-throughput serosurveillance of SARS-CoV-2
Joachim Mariën, Johan Míchiels, Leo Heyndríckx, Antoine Nkuba-Ndaye, Ann Ceulemans, Koen Bartholomeeusen, Joule Ntwan Madinga, Placide Mbala Kingebeni, Veerle Vanlerberghe, Steve Ahuka‐Mundeke et al. · 2021 · Journal of Virological Methods
Longitudinal observation of antibody responses for 14 months after SARS-CoV-2 infection
Puya Dehgani‐Mobaraki, Asiya Kamber Zaidi, Nidhi Yadav, A. Floridi, Emanuela Floridi · 2021 · Clinical Immunology
Demystifying mRNA vaccines: an emerging platform at the forefront of cryptic diseases
Nusrat Zahan Rouf, Sumit Biswas, Nawseen Tarannum, Labiba Mustabina Oishee, Mutia Masuka Muna · 2022 · RNA Biology
Mechanistic Insights Into the Immune Pathophysiology of COVID-19; An In-Depth Review
Areez Shafqat, Shameel Shafqat, Sulaiman Alsalameh, Junaid Kashir, Khaled Manae AlKattan, Ahmed Yaqinuddin · 2022 · Frontiers in Immunology
Mild SARS-CoV-2 infection in rhesus macaques is associated with viral control prior to antigen-specific T cell responses in tissues
Christine E. Nelson, S. Namasivayam, Taylor W. Foreman, Keith D. Kauffman, Shunsuke Sakai, Danielle E. Dorosky, N. Lora, Kelsie Brooks, E. L. Potter, N. Garza et al. · 2022 · bioRxiv
TNF-α+ CD4+ T cells dominate the SARS-CoV-2 specific T cell response in COVID-19 outpatients and are associated with durable antibodies
Kattria van der Ploeg, Adam S. Kirosingh, Diego AM Mori, Saborni Chakraborty, Zicheng Hu, Benjamín L. Sievers, Karen Blake Jacobson, Hector Fabio Bonilla, Julie Parsonnet, Jason Randolph Andrews et al. · 2022 · Cell Reports Medicine
SARS-CoV-2 infection and vaccination trigger long-lived B and CD4+ T lymphocytes with implications for booster strategies
Alessio Mazzoni, Anna Vanni, Michele Spinicci, Giulia Lamacchia, Seble Tekle Kiros, Arianna Rocca, Manuela Capone, Nicoletta Di Lauria, Lorenzo Salvati, Alberto Carnasciali et al. · 2022 · DOAJ (DOAJ: Directory of Open Access Journals)
Anti-SARS-CoV-2 Antibodies Persist for up to 13 Months and Reduce Risk of Reinfection
Gallais, Floriane, Gantner, Pierre, Bruel, Timothée, Velay, Aurelie, Planas, Delphine, Wendling, Marie-Josée, Bayer, Sophie, Solis, Morgane, Laugel, Elodie, Reix, Nathalie et al. · 2021
Antibody responses to BNT162b2 mRNA vaccine: Infection‐naïve individuals with abdominal obesity warrant attention
Alexis Elias Malavazos, Sara Basilico, Gianluca Iacobellis, Valentina Milani, Rosanna Cardani, Federico Boniardi, Carola Dubini, Ilaria Prandoni, Gloria Capitanio, Laura Valentina Renna et al. · 2021 · Obesity
The unnaturalistic fallacy: COVID-19 vaccine mandates should not discriminate against natural immunity
Jonathan Pugh, Julian Savulescu, Rebecca C. H. Brown, Dominic J. C. Wilkinson · 2022 · Journal of Medical Ethics
Specific Anti-SARS-CoV-2 Humoral and Cellular Immune Responses After Booster Dose of BNT162b2 Pfizer-BioNTech mRNA-Based Vaccine: Integrated Study of Adaptive Immune System Components
Rosalia Busà, Maria Concetta Sorrentino, Giovanna Russelli, Giandomenico Amico, Vitale Miceli, Monica Miele, Mariangela Di Bella, Francesca Timoneri, Alessia Gallo, Giovanni Zito et al. · 2022 · Frontiers in Immunology
Persistent Spike-specific T cell immunity despite antibody reduction after 3 months from SARS-CoV-2 BNT162b2-mRNA vaccine
Chiara Agrati, Concetta Castilletti, Delia Goletti, Alessandra Sacchi, Veronica Bordoni, Davide Mariotti, Stefania Notari, Giulia Matusali, Silvia Meschi, Linda Petrone et al. · 2022 · Scientific Reports
Immunological memory to common cold coronaviruses assessed longitudinally over a three-year period pre-COVID19 pandemic
Esther Dawen Yu, Tara M. Narowski, Eric W. Wang, Emily Garrigan, José Mateus, April Frazier, Daniela Weiskopf, Alba Grifoni, Lakshmanane Premkumar, Ricardo da Silva Antunes et al. · 2022 · Cell Host & Microbe
Human IgM–expressing memory B cells
Bettina Budeus, Artur Kibler, Ralf Küppers · 2023 · Frontiers in Immunology
Immunogenicity and reactogenicity of intradermal mRNA-1273 SARS-CoV-2 vaccination: a non-inferiority, randomized-controlled trial
Margaretha L.M. Prins, Geert V.T. Roozen, Cilia R. Pothast, Wesley Huisman, Rob S. van Binnendijk, Gerco den Hartog, Vincent P. Kuiper, Corine Prins, Jacqueline J. Janse, Olivia A. C. Lamers et al. · 2024 · npj Vaccines
SARS-CoV-2 antibody seroprevalence follow-up in Malagasy blood donors during the 2020 COVID-19 Epidemic
Matthieu J. Schoenhals, Niry Rabenindrina, Jean Marius Rakotondramanga, Philippe Dussart, Rindra Vatosoa Randremanana, Jean‐Michel Héraud, Soa Fy Andriamandimby, Paquerette Hanitriniala Sahondranirina, Manuela Christophère Vololoniaina, Fidiniaina Mamy Randriatsarafara et al. · 2021 · EBioMedicine
Immunity after COVID-19 and vaccination: follow-up study over 1 year among medical personnel
Vivian Glück, Sonja Grobecker, Josef Köstler, Leonid Tydykov, Manuela Bertok, Tanja Weidlich, Christine Gottwald, Bernd Salzberger, Ralf Wagner, Florian Zeman et al. · 2021 · Infection
The mutational landscape of SARS-CoV-2 variants diversifies T cell targets in an HLA-supertype-dependent manner
David J. Hamelin, Dominique Fournelle, Jean‐Christophe Grenier, Jana Schockaert, Kevin A. Kovalchik, Peter Kubiniok, Fatima Mostefai, Jérôme D. Duquette, Frederic Saab, Isabelle Sirois et al. · 2021 · Cell Systems
Mild and Asymptomatic COVID-19 Convalescents Present Long-Term Endotype of Immunosuppression Associated With Neutrophil Subsets Possessing Regulatory Functions
Izabela Siemińska, Kazimierz Węglarczyk, Marcin Surmiak, Dorota Kurowska-Baran, Marek Sanak, Maciej Siedlar, Jarek Baran · 2021 · Frontiers in Immunology
SARS-CoV-2 antibody and T cell responses one year after COVID-19 and the booster effect of vaccination: A prospective cohort study
Willem Ashwin Mak, Johannes G.M. Koeleman, Marijke van der Vliet, Frans Keuren, David S. Y. Ong · 2021 · Journal of Infection
Durability of Antibody Response and Frequency of SARS-CoV-2 Infection 6 Months after COVID-19 Vaccination in Healthcare Workers
Eric D. Laing, Carol D. Weiss, Emily C Samuels, Si’Ana A. Coggins, Wei Wang, Richard Wang, Russell A. Vassell, Spencer L. Sterling, Marana S Tso, Tonia L. Conner et al. · 2022 · Emerging infectious diseases
Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2)–Specific T Cells and Antibodies in Coronavirus Disease 2019 (COVID-19) Protection: A Prospective Study
Ivan A. Molodtsov, Evgenii Kegeles, Alexander N. Mitin, Olga N. Mityaeva, Oxana E. Musatova, Anna E. Panova, Mikhail V. Pashenkov, Iuliia O. Peshkova, Almaqdad Alsalloum, Walaa Asaad et al. · 2022 · Clinical Infectious Diseases
Long-Term Course of Humoral and Cellular Immune Responses in Outpatients After SARS-CoV-2 Infection
Julia Schiffner, Insa Backhaus, Jens Rimmele, Sören Schulz, Till Möhlenkamp, Julia Maria Klemens, Dorinja Zapf, Werner Solbach, Alexander Mischnik · 2021 · Frontiers in Public Health
Does the EU COVID Digital Certificate Strike a Reasonable Balance between Mobility Needs and Public Health?
Gianluca Montanari Vergallo, Simona Zaami, F Negro, Pietro Brunetti, Alessandro DEL RIO, Enrico Marinelli · 2021 · Medicina
Additive effects of booster mRNA vaccination and SARS-CoV-2 Omicron infection on T cell immunity across immunocompromised states
Thomas R Müller, Takuya Sekine, Darya Trubach, Julia Niessl, Puran Chen, Peter Bergman, Ola Blennow, Lotta Hansson, Stephan Mielke, Piotr Nowak et al. · 2023 · Science Translational Medicine
Divergent adaptive immune responses define two types of long COVID
Jérôme Kervevan, Isabelle Staropoli, Dorsaf Slama, Raphaël Jeger‐Madiot, Françoise Donnadieu, Delphine Planas, M P Pietri, Wiem Loghmari-Bouchneb, Motolete Alaba Tanah, Rémy Robinot et al. · 2023 · Frontiers in Immunology
Accelerated immune ageing is associated with COVID-19 disease severity
Janet M. Lord, Tonny Veenith, Jack Sullivan, Archana Sharma‐Oates, Alex G Richter, Neil J. Greening, Hamish J. C. McAuley, Rachael A Evans, Paul A. H. Moss, Shona C. Moore et al. · 2024 · Immunity & Ageing
Evolution of SARS-CoV-2 T cell responses as a function of multiple COVID-19 boosters
Ricardo da Silva Antunes, Vicente Fajardo-Rosas, Esther Dawen Yu, Rosa Isela Gálvez, Adam Abawi, E. Alexandar Escarrega, Amparo Martínez-Pérez, Emil Johansson, Benjamin Goodwin, April Frazier et al. · 2025 · Cell Reports
Sera Neutralizing Activities Against Severe Acute Respiratory Syndrome Coronavirus 2 and Multiple Variants 6 Months After Hospitalization for Coronavirus Disease 2019
Maureen Betton, Marine Livrozet, Delphine Planas, Antoine Fayol, Blandine Monel, Benoı̂t Vedie, Timothée Bruel, Éric Tartour, Nicolas Robillard, Jean‐Claude Manuguerra et al. · 2021 · Clinical Infectious Diseases
The mRNA-1273 Vaccine Induces Cross-Variant Antibody Responses to SARS-CoV-2 With Distinct Profiles in Individuals With or Without Pre-Existing Immunity
Sonia Tejedor Vaquero, Leire de Campos‐Mata, José María Ramada, Pilar Díaz, Juan Navarro‐Barriuso, Clara Ribas‐Llauradó, Natalia Rodrigo Melero, Carlo Carolis, Andrea Cerutti, Ramón Gimeno et al. · 2021 · Frontiers in Immunology
Function Is More Reliable than Quantity to Follow Up the Humoral Response to the Receptor-Binding Domain of SARS-CoV-2-Spike Protein after Natural Infection or COVID-19 Vaccination
Carlos A. Sariol, Petraleigh Pantoja, Crisanta Serrano-Collazo, Tiffany Rosa-Arocho, Albersy Armina-Rodríguez, Lorna A. Cruz, E. Taylor Stone, Teresa Arana, Consuelo Climent, Gerardo Latoni et al. · 2021 · Viruses
Safety and immunogenicity of inactivated COVID‐19 vaccine in health care workers
Saovanee Benjamanukul, Sasiwimon Traiyan, Ritthideach Yorsaeng, Preeyaporn Vichaiwattana, Natthinee Sudhinaraset, Nasamon Wanlapakorn, Yong Poovorawan · 2021 · Journal of Medical Virology
Perception, Prevalence, and Prediction of Severe Infection and Post-acute Sequelae of COVID-19
Dacre R. T. Knight, Bala Munipalli, Ilana I. Logvinov, Meghana G. Halkar, Ghada Mitri, Abd Moain Abu Dabrh, Stephanie L. Hines · 2022 · The American Journal of the Medical Sciences
Obesity and Leptin Resistance in the Regulation of the Type I Interferon Early Response and the Increased Risk for Severe COVID-19
Frits A.J. Muskiet, Pedro Carrera‐Bastos, Leo Pruimboom, Alejandro Lucía, David Furman · 2022 · Nutrients
Long-term persistence of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) spike protein-specific and neutralizing antibodies in recovered COVID-19 patients
Jira Chansaenroj, Ritthideach Yorsaeng, Jiratchaya Puenpa, Nasamon Wanlapakorn, Chintana Chirathaworn, Natthinee Sudhinaraset, Manit Sripramote, Piti Chalongviriyalert, Supunee Jirajariyavej, Phatharaporn Kiatpanabhikul et al. · 2022 · PLoS ONE
Evaluation of the systemic and mucosal immune response induced by COVID-19 and the BNT162b2 mRNA vaccine for SARS-CoV-2
Olaf Nickel, Alexandra Rockstroh, Johannes Wolf, Susann Landgraf, Sven Kalbitz, Nils Kellner, Michael Borte, Corinna Pietsch, Jasmin Fertey, Christoph Lübbert et al. · 2022 · PLoS ONE
Phase I/II trial of a peptide-based COVID-19 T-cell activator in patients with B-cell deficiency
Jonas S. Heitmann, Claudia Tandler, Maddalena Marconato, Annika Nelde, Timorshah Habibzada, Susanne Malaika Rittig, Christian Martin Tegeler, Yacine Maringer, Simon U. Jaeger, Monika Denk et al. · 2023 · Nature Communications
Humoral and cell-mediated response against SARS-CoV-2 variants elicited by mRNA vaccine BNT162b2 in healthcare workers: a longitudinal observational study
Irene Cassaniti, Federica Bergami, Elena Percivalle, Elisa Gabanti, Josè Camilla Sammartino, Alessandro Ferrari, Kodjo Messan Guy Adzasehoun, Federica Zavaglio, Paola Zelini, Giuditta Comolli et al. · 2021 · Clinical Microbiology and Infection
An FcRn-targeted mucosal vaccine against SARS-CoV-2 infection and transmission
Weizhong Li, Tao Wang, Arunraj Mekhemadhom Rajendrakumar, Gyanada Acharya, Zizhen Miao, Berin P. Varghese, Hailiang Yu, Bibek Dhakal, Tanya LeRoith, Athira Cheruplackal Karunakaran et al. · 2023 · Nature Communications
Somatic hypermutation introduces bystander mutations that prepare SARS-CoV-2 antibodies for emerging variants
Michael Korenkov, Matthias Zehner, Hadas Cohen‐Dvashi, Aliza Borenstein-Katz, Lisa Kottege, Hanna Janicki, Kanika Vanshylla, Timm Weber, Henning Gruell, Manuel Koch et al. · 2023 · Immunity
Gene replacement therapy in Bietti crystalline corneoretinal dystrophy: an open-label, single-arm, exploratory trial
Jinyuan Wang, Jinlu Zhang, Shicheng Yu, Hongyan Li, Shaohong Chen, Jingting Luo, Haibo Wang, Yuxia Guan, Haihan Zhang, Shiyi Yin et al. · 2024 · Signal Transduction and Targeted Therapy
What We Do Know and Do Not Yet Know about COVID-19 Vaccines as of the Beginning of the Year 2021
Jin‐Hong Yoo · 2021 · Journal of Korean Medical Science
Health care worker seromonitoring reveals complex relationships between common coronavirus antibodies and COVID-19 symptom duration
Sigrid Gouma, Madison E. Weirick, Marcus J. Bolton, Claudia P. Arevalo, Eileen C. Goodwin, Elizabeth M. Anderson, Christopher M. McAllister, Shannon R. Christensen, Debora Dunbar, Danielle Fiore et al. · 2021 · JCI Insight
Mechanism of a COVID-19 nanoparticle vaccine candidate that elicits a broadly neutralizing antibody response to SARS-CoV-2 variants
Yi-Nan Zhang, Jennifer Paynter, Cindy Sou, Tatiana Fourfouris, Ying Wang, Ciril Abraham, Timothy Ngo, Yi Zhang, Linling He, Jiang Zhu · 2021 · Science Advances
Infection induced SARS-CoV-2 seroprevalence and heterogeneity of antibody responses in a general population cohort study in Catalonia Spain
Marianna Karachaliou, Gemma Moncunill, Ana Espinosa, Gemma Castaño‐Vinyals, Alfons Jiménez, Marta Vidal, Rebeca Santano, Diana Barrios, Laura Puyol, Anna Carreras et al. · 2021 · Scientific Reports
Milk From Women Diagnosed With COVID-19 Does Not Contain SARS-CoV-2 RNA but Has Persistent Levels of SARS-CoV-2-Specific IgA Antibodies
Ryan M. Pace, Janet E. Williams, Kirsi M. Järvinen, Courtney L. Meehan, Melanie Ann Martin, Sylvia H. Ley, Celestina Barbosa‐Leiker, Aline Andres, Laxmi Yeruva, Mandy B. Belfort et al. · 2021 · Frontiers in Immunology
Clinical Performance of a Standardized Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Interferon-γ Release Assay for Simple Detection of T-Cell Responses After Infection or Vaccination
Marta Fernández‐González, Vanesa Agulló, Sergio Padilla, José Alberto García, Javier García‐Abellán, Ángela Botella, Paula Mascarell, Montserrat Ruiz‐García, Mar Masiá, Félix Gutiérrez · 2021 · Clinical Infectious Diseases
Children and Adults With Mild COVID-19: Dynamics of the Memory T Cell Response up to 10 Months
Patricia Kaaijk, Veronica Olivo Pimentel, Maarten E. Emmelot, Martien C. M. Poelen, Alper Çevirgel, Rutger M. Schepp, Gerco den Hartog, Daphne F. M. Reukers, Lisa Beckers, Josine van Beek et al. · 2022 · Frontiers in Immunology
Neutralizing Antibodies and Cellular Immune Responses Against SARS-CoV-2 Sustained One and a Half Years After Natural Infection
Lina Yan, Panpan Liu, Xu-gui Li, Shi-jing Zhou, Hao Li, Zhi-yin Wang, Feng Shen, Bichao Lu, Yu Long, Xiao Xiao et al. · 2022 · Frontiers in Microbiology
SARS-CoV-2-specific CD4+ T cells are associated with long-term persistence of neutralizing antibodies
Zhongfang Wang, Xiaoyun Yang, Xinyue Mei, Yumin Zhou, Zhiqiang Tang, Guichang Li, Jiaying Zhong, Mengqiu Yu, Mingzhu Huang, Xiaoling Su et al. · 2022 · Signal Transduction and Targeted Therapy